Treatment Navigation for Opioid Use Disorder

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-20

Study Completion Date

2019-09-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will conduct a pilot randomized controlled trial (RCT) study of 100 people with a history of opioid use disorder releasing to WA Department of Corrections (DOC) community corrections supervision in King County. Half of the subjects will receive treatment as usual (e.g. referral to treatment or outpatient drug counseling by DOC community corrections staff) and half will receive 6 months of intervention. The intervention involves treatment decision making, in which the study interventionists help subjects understand treatment choices, decide on the treatment that is best for them, get enrolled in treatment and remain in treatment. The study does not provide treatment, but works with treatment providers to facilitate access to care.

The aims of this study are to determine: 1) whether study procedures can be implemented with as designed, 2) whether offenders can be enrolled and maintained in the study, 3) which medications/treatment options subjects select and their experiences and satisfaction with the interventions, and 4) preliminary intervention effect size on outcomes of interest including recidivism, drug use, hospitalization, and treatment enrollment and retention.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder

NCT04797962

Opioid-use Disorder

COMPLETED NA

Therapy for People With Opioid Use Disorder

NCT06008769

Opioid Use Disorder

ACTIVE_NOT_RECRUITING NA

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

NCT05288751

Opioid Use Disorder Stimulant Use Disorder

ACTIVE_NOT_RECRUITING NA

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD

NCT03658642

Clinical Decision Support Buprenorphine Opioid-use Disorder

COMPLETED NA

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

NCT05817825

Opioid Use Disorder Serious Bacterial Infections

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid-use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Initial discussion regarding opioid treatment options followed by 6 months of treatment navigation.

Group Type EXPERIMENTAL

Treatment Navigation (Intervention)

Intervention Type BEHAVIORAL

Subjects in the intervention arm will begin a discussion with the interventionist about whether they are interested in treatment and medication choices for opioid use disorder. The interventionist will use a decision tool informed by the Substance Abuse and Mental Health Services Administration (SAMSHA) guide to medication assisted treatment in order to help make an informed decision about treatment choices. Once a decision is reached, the Treatment Navigator will communicate with the subject periodically to assist with entering treatment and help with locating other social services as needed within the community. The Treatment Navigator will emphasize getting into treatment as quickly as possible once a decision is made. The Treatment Navigator and the subject will continue communicating throughout the 6 month study period. Subjects will also receive overdose education and be offered take-home naloxone.

Control

Referrals to treatment from corrections staff.

Group Type OTHER

Control

Intervention Type OTHER

Subjects in the control arm will receive referrals from Department of Corrections (DOC) staff for treatment per DOC protocols. Subjects will not receive any treatment navigation or treatment decision making. Subjects will also receive overdose education and be offered take-home naloxone.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment Navigation (Intervention)

Subjects in the intervention arm will begin a discussion with the interventionist about whether they are interested in treatment and medication choices for opioid use disorder. The interventionist will use a decision tool informed by the Substance Abuse and Mental Health Services Administration (SAMSHA) guide to medication assisted treatment in order to help make an informed decision about treatment choices. Once a decision is reached, the Treatment Navigator will communicate with the subject periodically to assist with entering treatment and help with locating other social services as needed within the community. The Treatment Navigator will emphasize getting into treatment as quickly as possible once a decision is made. The Treatment Navigator and the subject will continue communicating throughout the 6 month study period. Subjects will also receive overdose education and be offered take-home naloxone.

Intervention Type BEHAVIORAL

Control

Subjects in the control arm will receive referrals from Department of Corrections (DOC) staff for treatment per DOC protocols. Subjects will not receive any treatment navigation or treatment decision making. Subjects will also receive overdose education and be offered take-home naloxone.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Treatment Navigation, Treatment Decision Making, Shared Decision Making

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Meets Diagnostic and Statistical Manual (DSM-5) criteria for opioid use disorder (at least 2 criteria) or were receiving treatment for opioid use disorder in the 12 months prior to incarceration.
2. Released to community corrections, not currently incarcerated.
3. Able to understand and provide informed consent.
4. Has access to phone (voice or text) or email to communicate with research staff.

Exclusion Criteria

1. Under age 18 or over age 70 at time of recruitment.
2. Currently enrolled in an opioid treatment program using medications.
3. Has not used opioids (prescription type or heroin) in the past 6 months prior to incarceration.
4. Unwilling to allow access to medical or drug treatment records, criminal history or criminal activity records.
5. Inability to communicate in English verbally.
6. Inability to provide adequate contact information to assist with follow-up.
7. Not planning on being in King County or reporting to community corrections in King County for 6 months.
8. Violent or overtly hostile/threatening towards research staff.
9. Entering a controlled environment for 31 days or more in the next 6 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No